Cargando…
Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp
BACKGROUND: Methotrexate (MTX) is an important anticancer agent and immunosuppressant with a narrow therapeutic window. Wuzhi capsule (WZC) is an extract of Schisandra which is widely used to treat liver diseases. Co-administration of MTX and WZC is common in the clinical setting, but research on th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184478/ https://www.ncbi.nlm.nih.gov/pubmed/34164479 http://dx.doi.org/10.21037/atm-21-1303 |
_version_ | 1783704598490382336 |
---|---|
author | Fu, Ran Wang, Xiao-Nan Guo, Cai-Hui Li, Ying Ding, Cong-Yang Li, Ya-Jing Dong, Zhan-Jun |
author_facet | Fu, Ran Wang, Xiao-Nan Guo, Cai-Hui Li, Ying Ding, Cong-Yang Li, Ya-Jing Dong, Zhan-Jun |
author_sort | Fu, Ran |
collection | PubMed |
description | BACKGROUND: Methotrexate (MTX) is an important anticancer agent and immunosuppressant with a narrow therapeutic window. Wuzhi capsule (WZC) is an extract of Schisandra which is widely used to treat liver diseases. Co-administration of MTX and WZC is common in the clinical setting, but research on the interaction between WZC and MTX is limited. This study aimed to investigate the effects of WZC on the pharmacokinetics of MTX in rats and to explore the role of membrane transport proteins OAT1/3 and P-gp in the interaction of these drugs. METHODS: Plasma MTX concentration was detected by ultra-performance liquid chromatography-tandem mass spectrometer (UPLC-MS/MS), and the messenger RNA (mRNA) and protein expression of OAT1/3 and P-gp was evaluated by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blotting analyses, respectively. RESULTS: The study results revealed that co-administration of WZC decreased the CL(z/F) and V(z/F) of MTX, increased the C(max) and area under the curve [(AUC)(0–24 h)] of MTX, and inhibited OAT1/3 expression in the kidney and P-gp expression in the small intestine. CONCLUSIONS: The findings suggested that there is a drug interaction between WZC and MTX and that OAT1/3 in the kidney and P-gp in the small intestine may be the main targets mediating the drug interaction, and attention should be paid when they are used in combination. |
format | Online Article Text |
id | pubmed-8184478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-81844782021-06-22 Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp Fu, Ran Wang, Xiao-Nan Guo, Cai-Hui Li, Ying Ding, Cong-Yang Li, Ya-Jing Dong, Zhan-Jun Ann Transl Med Original Article BACKGROUND: Methotrexate (MTX) is an important anticancer agent and immunosuppressant with a narrow therapeutic window. Wuzhi capsule (WZC) is an extract of Schisandra which is widely used to treat liver diseases. Co-administration of MTX and WZC is common in the clinical setting, but research on the interaction between WZC and MTX is limited. This study aimed to investigate the effects of WZC on the pharmacokinetics of MTX in rats and to explore the role of membrane transport proteins OAT1/3 and P-gp in the interaction of these drugs. METHODS: Plasma MTX concentration was detected by ultra-performance liquid chromatography-tandem mass spectrometer (UPLC-MS/MS), and the messenger RNA (mRNA) and protein expression of OAT1/3 and P-gp was evaluated by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blotting analyses, respectively. RESULTS: The study results revealed that co-administration of WZC decreased the CL(z/F) and V(z/F) of MTX, increased the C(max) and area under the curve [(AUC)(0–24 h)] of MTX, and inhibited OAT1/3 expression in the kidney and P-gp expression in the small intestine. CONCLUSIONS: The findings suggested that there is a drug interaction between WZC and MTX and that OAT1/3 in the kidney and P-gp in the small intestine may be the main targets mediating the drug interaction, and attention should be paid when they are used in combination. AME Publishing Company 2021-05 /pmc/articles/PMC8184478/ /pubmed/34164479 http://dx.doi.org/10.21037/atm-21-1303 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Fu, Ran Wang, Xiao-Nan Guo, Cai-Hui Li, Ying Ding, Cong-Yang Li, Ya-Jing Dong, Zhan-Jun Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp |
title | Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp |
title_full | Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp |
title_fullStr | Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp |
title_full_unstemmed | Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp |
title_short | Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp |
title_sort | wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of oat1/3 and p-gp |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184478/ https://www.ncbi.nlm.nih.gov/pubmed/34164479 http://dx.doi.org/10.21037/atm-21-1303 |
work_keys_str_mv | AT furan wuzhicapsuleincreasedsystemicexposuretomethotrexatebyinhibitingtheexpressionofoat13andpgp AT wangxiaonan wuzhicapsuleincreasedsystemicexposuretomethotrexatebyinhibitingtheexpressionofoat13andpgp AT guocaihui wuzhicapsuleincreasedsystemicexposuretomethotrexatebyinhibitingtheexpressionofoat13andpgp AT liying wuzhicapsuleincreasedsystemicexposuretomethotrexatebyinhibitingtheexpressionofoat13andpgp AT dingcongyang wuzhicapsuleincreasedsystemicexposuretomethotrexatebyinhibitingtheexpressionofoat13andpgp AT liyajing wuzhicapsuleincreasedsystemicexposuretomethotrexatebyinhibitingtheexpressionofoat13andpgp AT dongzhanjun wuzhicapsuleincreasedsystemicexposuretomethotrexatebyinhibitingtheexpressionofoat13andpgp |